LimmaTech secures funding for vaccine technology development

LimmaTech announced the closing of a second round of its Series A financing, securing $3m from Tenmile for vaccine technology development.

Feb 2, 2024 - 18:00

LimmaTech secures funding for vaccine technology development

LimmaTech announced the closing of a second round of its Series A financing, securing $3m from Tenmile for vaccine technology development.

Read the original article

Tags:

Previous Article

Scottish company secures £4.2m to advance 3D-printed micro-tumour tech

Biosyngen’s liver cancer therapy receives fast track designation

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Bangladesh and the dengue vaccine question

Bangladesh and the dengue vaccine question

Aug 4, 2023

Focus Covid booster campaigns on high-risk people, WHO’s vaccine experts recommend

Focus Covid booster campaigns on high-risk people, WHO’...

Mar 28, 2023

STAT+: Senate working group proposes 340B reforms

STAT+: Senate working group proposes 340B reforms

Feb 3, 2024